Whanin Pharm환인제약
016580 · KOSPI · ₩016580 · 환인제약
₩10,480▲ ₩340 (3.35%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 36.2% | 34.1% | 36.1% | 43.0% | 49.7% | 52.6% |
| Operating margin | 8.2% | 5.1% | 8.3% | 13.1% | 15.0% | 17.6% |
| Net margin | 7.5% | 5.3% | 9.0% | 12.9% | 12.0% | 15.0% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +7.2% | −1.7% | +12.7% | +15.8% | +11.9% | — |
| Operating income growth | +71.4% | −39.4% | −28.8% | +1.2% | −4.7% | — |
| Net income growth | +50.4% | −41.9% | −21.5% | +24.5% | −10.3% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 4.8% | 3.4% | 6.4% | 8.6% | 7.4% | 8.4% |
| Return on assets | 3.8% | 3.0% | 5.7% | 7.7% | 6.6% | 7.5% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 13.4% | 13.7% | 13.0% | 12.0% | 10.6% | 11.3% |
| Net debt to equity | −15.0% | −14.6% | −11.0% | −16.3% | −14.4% | −26.8% |
| Current ratio | 425.8% | 404.0% | 475.0% | 529.9% | 621.8% | 784.5% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Whanin Pharm / 환인제약 / 016580 / KRX:016580
Source: KRX statistical information